Mirum Pharmaceuticals, Inc.

NASDAQ:MIRM

40.45 (USD) • At close November 4, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q3
Omzet 77.87569.22269.55447.72537.49731.59827.90618.7817.48412.8923.13851100000000000
Kosten van de omzet 20.38117.8322.60410.2286.8124.9794.4942.9322.5242.4241.903000.1850000000000
Brutowinst 57.49451.39246.9537.49730.68526.61923.41215.84814.9610.4681.235511-0.1850000000000
Brutowinstmarge 0.7380.7420.6750.7860.8180.8420.8390.8440.8560.8120.3941100000000000
Onderzoek- en ontwikkelingskosten 32.51832.22230.84126.11722.00923.54831.10526.21725.43224.08827.77530.47135.04838.13429.72615.98418.55517.3414.3812.15911.5894.86325.2290.003
Algemene en administratieve kosten 41.237039.884032.949016.957020.969019.03517.35313.3539.4797.2255.7325.0424.6924.2783.7082.4451.3210.8060.062
Verkoop- en marketingkosten 7.97106.305.68509.51100000000000000000
Verkoop-, algemene en administratieve kosten 49.20845.63846.18436.52832.94930.21926.46822.51320.96919.11619.03517.35313.3539.4797.2255.7325.0424.6924.2783.7082.4451.3210.8060.062
Overige kosten 0.3121.75746.0151.322-49.35-0.811-0.588-0.1921.299-0.154107.983-0.035-0.514-0.016-0.083-0.03-0.056-0.023-0.02-0.0050.009-0.00500
Bedrijfskosten 81.72677.8677.02562.64554.95853.76757.57348.7346.40143.20446.8147.82448.40147.61336.95121.71623.59722.03218.65815.86714.0346.18426.0340.065
Bedrijfsresultaat -24.232-26.468-30.075-25.148-24.273-27.148-34.161-32.882-31.441-32.736-45.575-42.824-37.401-47.613-36.951-21.716-23.597-22.032-18.658-15.867-14.034-6.184-4.299-0.065
Bedrijfsresultaat ratio -0.311-0.382-0.432-0.527-0.647-0.859-1.224-1.751-1.798-2.539-14.524-8.565-3.400000000000
Totaal overige inkomsten en kosten netto 0.2291.757-2.8491.809-49.35-2.781-2.13-2.811-2.051-3.859106.8341.32-1.7860.318-0.083-0.03-0.056-0.023-0.02-0.0050.0090.227-21.646-0.002
Inkomen voor belasting -24.003-24.655-32.924-23.339-73.722-29.929-36.291-35.693-33.492-36.59557.558-47.099-43.883-50.527-37.201-21.509-23.248-21.306-17.931-15.087-13.557-5.957-25.945-0.067
Inkomen voor belasting ratio -0.308-0.356-0.473-0.489-1.966-0.947-1.3-1.901-1.916-2.83918.342-9.42-3.98900000000000
Belastingkosten 0.6350.6240.2250.2490.3160.2010.140.013-6.570.0110.0120.0090.0110.0050.002-0.0030.0030.0040.021-0.785-0.4680.232-21.646-0.065
Nettowinst -24.638-25.279-33.149-23.588-74.038-30.13-36.431-35.706-26.922-36.60657.546-47.108-43.894-50.532-37.203-21.506-23.251-21.31-17.952-15.087-13.557-5.957-25.945-0.067
Nettowinstmarge -0.316-0.365-0.477-0.494-1.975-0.954-1.305-1.901-1.54-2.83918.338-9.422-3.9900000000000
WPA (Winst Per Aandeel) -0.52-0.54-0.71-0.57-1.94-0.8-0.99-1.02-0.84-1.171.88-1.55-1.45-1.68-1.43-0.86-0.93-0.86-0.79-0.84-0.59-0.6-9.52-0.007
Verwaterde WPA -0.52-0.54-0.71-0.57-1.94-0.8-0.97-1.02-0.84-1.171.88-1.55-1.45-1.68-1.43-0.86-0.93-0.86-0.79-0.84-0.59-0.6-9.52-0.007
EBITDA -18.378-15.414-24.676-25.148-69.996-24.206-32.606-30.518-29.144-32.37862.91-42.609-37.66-47.295-36.866-21.561-23.45-21.876-18.658-15.778-13.946-5.925-21.646-0.065
EBITDA ratio -0.236-0.223-0.355-0.527-1.867-0.766-1.168-1.625-1.667-2.51120.048-8.522-3.42400000000000